Shareefa A. Alghamdi
Jeddah, 21589, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
RETRACTED: Alhakamy et al. Ceftriaxone and Melittin Synergistically Promote Wound Healing in Diabetic Rats. Pharmaceutics 2021, 13, 1622.
Journal: Pharmaceutics
Published: August 30, 2024
Undesirable effects of COVID-19 vaccination on Saudi population: A descriptive study, Winter 2022.
Journal: International journal of health sciences
Published: July 08, 2024
Effectiveness of Vitamin D on Neurological and Mental Disorders.
Journal: Diseases (Basel, Switzerland)
Published: May 17, 2024
Evaluation of the vitamin D response index in a Saudi cohort.
Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: March 19, 2024
Evaluation of the vitamin D response index in a Saudi cohort.
Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: March 19, 2024
Serum Ghrelin and Leptin Concentrations in Patients with Major Depressive Disorder before and after Supplementation with Vitamin D3.
Journal: Depression and anxiety
Published: December 29, 2023
Influence of rosiridin on streptozotocin-induced diabetes in rodents through endogenous antioxidants-inflammatory cytokines pathway and molecular docking study.
Journal: Journal of biomolecular structure & dynamics
Published: November 20, 2023
Review of the potential pharmacological role of erucic acid: a monounsaturated omega-9 fatty acid.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: October 07, 2023
Unleashing the potential of catalytic RNAs to combat mis-spliced transcripts.
Journal: Frontiers in bioengineering and biotechnology
Published: June 22, 2023
Rosinidin inhibits NF-κB/ Nrf2/caspase-3 expression and restores neurotransmitter levels in rotenone-activated Parkinson's disease.
Journal: Saudi journal of biological sciences
Published: February 27, 2023
Barbigerone prevents scopolamine-induced memory impairment in rats by inhibiting oxidative stress and acetylcholinesterase levels.
Journal: Royal Society open science
Published: January 27, 2023
Investigating a Library of Flavonoids as Potential Inhibitors of a Cancer Therapeutic Target MEK2 Using in Silico Methods.
Journal: International journal of molecular sciences
Published: January 19, 2023
Last Updated: 09/26/2026